Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Ulcerative sarcoidosis in body folds is rare and improved with prednisone and hydroxychloroquine.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Pregnant women with rheumatic diseases often have poor nutrition, needing more folic acid, calcium, and iron, while consuming too much selenium.

A patient with complete hair loss regrew all her hair using tofacitinib.

HS needs personalized treatment plans and more research.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Finasteride for hair loss doesn't harm erectile function; weight loss and exercise improve it.

Deucravacitinib helped a man regrow hair and improve psoriasis.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Finasteride doesn't reduce sexual function in people with hair loss.

New scale reliably assesses male hair loss with female pattern.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

IBS is linked to certain skin conditions like psoriasis and rosacea, and vice versa.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

Finasteride for hair loss has minimal impact on sexual function.

Adalimumab can cause complete hair loss in rare cases.

WAA-QOL measures impact of hair loss on women's well-being.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.